ASRM 2007 Annual Meeting

Monday, October 15 
Overview

Go back to Sunday's Overview | Go to Tuesday's Overview

SPECIAL PRESENTATION
7:00 am-7:55 am
Room: Ballroom ABC

Speaker and Session Introduction: Early Studies into Hot Flushes
Robert F.J. Casper, M.D.

Pathophysiology of Hot Flushes: It’s All in Your Head
Robert R. Freedman, Ph.D.

Needs Assessment and Description:
Hot flashes are experienced by the majority of women around menopause but practitioners know little about them. This presentation will detail what is known about the central and peripheral mechanisms of hot flashes and their effects on sleep. Treatment options are not ideal at this time, but a better understanding of pathophysiology will eventually lead to better treatment.

Back to the Top

PLENARY SESSION I
8:00 am - 9:30 am
Room: Ballroom ABC
Chair: Steven J. Ory, M.D.

8:00 am
PRESIDENT'S GUEST LECTURER/TAP PHARMACEUTICAL ENDOWED LECTURE
The World of Genomics: What Does it Mean for Medicine?
John Quackenbush, Ph.D.

8:45 am
HERBERT H. THOMAS ORTHO WOMEN’S HEALTH ENDOWED LECTURE
Human Pheromones: Effects on Fertility, Sexuality and Emotions
Martha K. McClintock, Ph.D.

Introduced by:
Dorothy Greenfeld, M.S.W.

Back to the Top

9:30 am - 10:15 am
Refreshments in Exhibit Hall D

MORNING CONCURRENT SESSIONS, INCLUDING SYMPOSIA
All rooms located in the Washington Convention Center.

GENERAL PROGRAM PRIZE PAPER CANDIDATES
Room: Ballroom ABC
10:15 am - 12:00 noon

Moderators:
William H. Catherino, M.D., Ph.D.
Pasquale Patrizio, M.D.

10:15 am O-1
ACCURATE 23 CHROMOSOME ANEUPLOIDY SCREENING IN HUMAN BLASTOMERES USING SINGLE NUCLEOTIDE POLYMORPHISM (SNP) MICROARRAYS.
N. R. Treff, J. Su, J. Mavrianos, P. A. Bergh, K. A. Miller, R. T. Scott, Jr.

10:30 am O-2
POSSIBLE INVOLVEMENT OF INTERLEUKIN-1 FAMILY IN THE REGULATION OF MOUSE MALE FERTILITY.
M. Huleihel, M. Ganaiem, M. Abu Elhija, T. Eldar-Geva, N. Weisz, E. Lunenfeld.

10:45 am O-3
EFFECT OF WEIGHT LOSS AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY ON THE MALE REPRODUCTIVE HORMONAL PROFILE.
A. O. Hammoud, M. Gibson, S. C. Hunt, D. Carrell, T. D. Adams, W. Meikle. (SREI Prize Paper and In-Training Award for Research)

11:00 am O-4
A->G POLYMORPHISM AT POSITION+331 IN THE PROGESTERONE RECEPTOR (PR) GENE IS STRONGLY ASSOCIATED WITH OOCYTE DONATION (OD) OUTCOME.
S. D. Spandorfer, A. Babayan, O. K. Davis, Z. Rosenwaks, S. S. Witkin.

11:15 am O-5
THE EFFECT OF EARLY FETAL LOSSES ON SINGLETON ASSISTED CONCEPTION PREGNANCY OUTCOMES.
B. Luke, M. B. Brown, D. A. Grainger, J. E. Stern, N. Klein, M. I. Cedars.

11:30 am O-6
POOR MINORITY WOMEN WITH STDS ARE CONCERNED ABOUT FUTURE PREGNANCY BUT DO NOT SEEK INFERTILITY EVALUATION.
J. R. Jensen, S. T. Perdue, A. E. Holden, R. N. Shain. (Mental Health Prize Paper)

11:45 am O-7
LOW-DOSE ACETYLSALICYLIC ACID (ASPIRIN) IS NOT BENEFICIAL IN A SELECTED GROUP OF IN-VITRO-FERTILISATION (IVF) AND INTRA-CYTOPLASMATIC SPERM-INJECTION (ICSI)- PATIENTS WITH PREVIOUS IMPLANTATION FAILURE.
M. J. Lambers, D. A. Hoozemans, R. Homburg, R. Schats, C. B. Lambalk, P. G. A. Hompes.

Back to the Top

MENOPAUSE DAY DEBATE
10:15 am-11:00 am
Bioidentical Hormones: Safe Choice Or High Risk For Menopause?
Room: 201

Chair: Cynthia K. Sites, M.D.

Presenters:
Con: John E. Buster, M.D.
Pro: Nanette F. Santoro, M.D.

Needs Assessment and Description:
Bioidentical hormones, or those that match the chemical structure of those produced naturally by the body, have been promoted as safer and more effective than traditional menopausal hormones on clinical outcomes such as breast, endometrium, bone, and brain. Although patients are reading more in the lay literature about these products and asking their physicians to prescribe them, physicians often have little information about long term safety and efficacy of these products. A greater understanding of the types and dosages of products available, FDA oversight of them, purity, and their safety and efficacy is needed.

Learning Objectives
At the conclusion of the presentation, attendees should be able to:

1. List the evidence supporting the safety and efficacy of bioidentical estrogens and progesterone on breast, endometrium, bone, and brain.

2. Describe the possible risks of using bioidentical hormones.

3. Summarize the gaps in current knowledge about the use of bioidentical estrogens (estradiol, estrone, estriol) and progesterone.

Back to the Top

The Society of Reproductive Surgeons (SRS) Live Telesurgeries
10:15 am-Noon
Room: 145AB

“Laparoscopic Myomectomy without a Robot”
Surgeon: Charles H. Koh, M.D.
Broadcast live from Columbia-St. Mary's Hospital Milwaukee Campus.

“Laparoscopic Myomectomy with a Robot”
Surgeon: Ceana H. Nezhat, M.D.
Broadcast live from Northside Hospital Atlanta.

Supported by an educational grant from ETHICON Women’s Health & Urology, Karl Storz Endoscopy- America, Inc., Intuitive Surgical

Back to the Top

11:00 am-12:00 pm
MENOPAUSE DAY
Mock Trial: My Bioidentical Estriol And Progesterone Caused My Breast Cancer
Room: 201

Judge: Cynthia K. Sites, M.D.
Plaintiff Attorney: David H. Barad, M.D.
Defense Attorney: John F. Randolph, Jr., M.D.
Plaintiff: Karen D. Bradshaw, M.D.
Defendant: Johanna S. Archer, M.D.
Jury: Audience

Needs Assessment and Description:
Bioidentical hormones, including estradiol, estrone, estriol, and progesterone, have been used in Europe in the past and are now becoming more popular in the United States partly due to increased publicity in the lay press. Women often ask their physicians to prescribe such compounds, and compounding pharmacies are willing to participate. Risks and benefits of these compounds, in particular the risk of breast cancer, is not well understood and will be examined in a mock trial setting.

Learning Objectives:
At the conclusion of this mock trial, attendees should be able to:

1. List evidence, pro and con, regarding the possible association of bioidentical hormones use and breast cancer risk.

2. Summarize the evidence regarding use of salivary hormone assays in monitoring levels of bioidentical hormones in post menopausal women.

3. As part of the jury, evaluate the evidence presented to determine if, within a reasonable degree of medical certainty, the bioidentical hormones in this case caused breast cancer.

   Back to the Top

   ---

Noon-1:30 pm
COMMERCIALLY SUPPORTED LUNCHEON SYMPOSIUM
Controversies in HPV Vaccination
Supported by an educational grant from Merck & Co., Inc.

Chair: Samantha M. Pfeifer, M.D.

Faculty:
Mark Spitzer, M.D.
John W. Ward, M.D.

Room: Hall A

Back to the Top

12:15 pm-1:15 pm
ROUNDTABLE LUNCHEONS
Room: Hall E

12:15 pm-1:15 pm
INTERACTIVE SESSIONS
All rooms located in the Washington Convention Center.

12:15 pm-1:15 pm
Meet the Professor:* Why Human Pheromones? Pheromones in the Reproductive Health of Women
Martha K. McClintock, Ph.D.
Room: 206
*A ticket is required for this activity. Lunch included.

Back to the Top

PLENARY SESSION II
1:30 pm-2:15 pm
Room: Ballroom ABC

Chair: R. Dale McClure, M.D.

1:30 pm
AMERICAN UROLOGICAL ASSOCIATION/BRUCE STEWART MEMORIAL LECTURE
Human Embryonic Stem Cell Differentiation: Toward Making Sperm and Eggs in a Dish
Renee A. Reijo Pera, Ph.D.

Introduced by: Rebecca Z. Sokol, M.D., M.P.H., President, SMRU

Needs Assessment and Description:
The human embryonic stem cell system holds great promise for genetic, pharmacological and developmental studies of sperm and egg formation. This presentation will describe recent findings.

Learning Objectives:
At the conclusion of the presentation, attendees should be able to:

1. Outline human germ cell formation.

2. Discuss human embryonic stem differentiation.

3. Describe future goals in this field.

Back to the Top

1:30 pm-2:15 pm
MENOPAUSE DAY KEYNOTE SPEAKER
The WHI Hormone Therapy Trials: Making Sense of the Evidence
JoAnn E. Manson, M.D., Dr.P.H.
Room: 201

Introduced by: Cynthia K. Sites, M.D.

Needs Assessment and Description:
Recent analyses provide insights that help to reconcile the randomized trial findings with results of earlier studies and have important implications for clinical decision making. Reports from the Women's Health Initiative and other randomized trials have led to considerable confusion about the appropriate role of hormone therapy in menopause management. Clinicians and patients are uncertain about the implications of recent findings for clinical decisionmaking about hormone therapy. There is a strong need to consider recent findings in the context of the entire evidence base on hormone therapy in order to improve clinical decision-making and optimize women's health care.

Learning Objectives:
At the conclusion of the presentation, attendees should be able to:

1. Interpret the recent findings from the Women's Health Initiative and other randomized trials and the implications for clinical decision-making about hormone therapy.

2. Identify appropriate candidates for hormone therapy and assess alternative treatment options for women who are found to be ineligible.

2:15 pm-3:00 pm
Refreshments in Exhibit Hall D

Back to the Top

AFTERNOON CONCURRENT SESSIONS
3:00 pm-5:00 pm
All rooms located in the Washington Convention Center.

REPRODUCTIVE BIOLOGISTS PROFESSIONAL GROUP ABSTRACTS
Room: 143C
3:00 pm-5:00 pm

Moderators:
Gary D. Smith, Ph.D.
Dawn A. Kelk, Ph.D.

3:00 pm O-8
SINGLE-BLASTOMERE WHOLE-GENOME DNA FINGERPRINTING RESULTS IN UNEQUIVOCAL EMBRYO IDENTIFICATION-A POWERFUL NEW CLINICAL AND DIAGNOSTIC TOOL.
N. R. Treff, J. Su, E. P. Bergh, B. Levy, K. A. Miller, R. T. Scott, Jr.

3:15 pm O-9
A PHASE OF CHROMOSOME AGGREGATION DURING MEIOSIS IN HUMAN OOCYTES.
J. Otsuki, Y. Nagai.

3:30 pm O-10
UNIQUE BIOMARKERS OF HUMAN OOCYTE MATURATION ASSESSED BY NON-INVASIVE METABOLOMIC PROFILING.
Z. P. Nagy, B. Behr, P. Roos, J. Dasig, D. Burns.

3:45 pm O-11
EXPRESSION AND LOCALIZATION OF THE NOVEL AND HIGHLYCONSERVED GERM-CELL SPECIFIC FACTOR 1 DURING EARLY OOGENESIS.
S. Krotz, D. Ballow, J. Buster, A. Rajkovic.

4:00 pm O-12
FREQUENCY OF SPERM CELLS WITH FRAGMENTED DNA IN MALES INFECTED WITH CHLAMYDIA TRACHOMATISAND MYCOPLASMA SP, DETERMINED WITH THE SPERM CHROMATIN DISPERSION (SCD) TEST.
J. L. Fernandez, B. Ramos, R. Santiso, A. Agarwal, J. Gosalvez, G. Gallegos.

4:15 pm O-13
DERIVATION OF MOUSE EMBRYONIC STEM CELLS (MESC) FROM INDIVIDUAL AND AGGREGATED MOUSE BLASTOMERES.
J. Hao, J. Pareja, N. Zaninovic.

4:30 pm O-14
DOXYCYCLINE INHIBITS VASCULAR LEAKAGE AND PREVENTS OVARIAN HYPERSTIMULATION SYNDROME (OHSS) IN A MURINE MODEL.
O. Fainaru, L. Bazinet, A. Adini, R. D'Amato, M. D. Hornstein, J. Folkman.

4:45 pm O-15
LOCAL LUTEOTROPIC ROLE OF THE CORTICOTROPIN RELEASING HORMONE/UROCORTINRECEPTOR-BINDING PROTEIN (CRH/UCN-R-BP) SYSTEM IN THE PRIMATE CORPUS LUTEUM (CL).
J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, R. L. Stouffer.

Back to the Top

MENOPAUSE SPECIAL INTEREST GROUP ABSTRACTS
Room: 201
3:00 pm-5:00 pm

Moderators:
Bruce Kessel, M.D.
Veronica A. Ravnikar, M.D.

3:00 pm O-16
THE ASSOCIATION OF LEPTIN LEVELS, HORMONE LEVELS AND HOT FLASHES IN MID-LIFE WOMEN.
C. J. Alexander, C. Schilling, L. Gallicchio, J. A. Flaws, H. A. Zacur.

3:15 pm O-17
BILATERAL OOPHORECTOMY AND DEPRESSION 12 MONTHS AFTER HYSTERECTOMY.
J. Rohl, K. Kjerulff, J. Steege.

3:30 pm O-18
IS ANTRAL FOLLICLE COUNT (AFC) A GENETIC TRAIT? PREDICTIVE ABILITY OF MOTHER'S MENOPAUSAL AGE.
S. J. Gillham, A. E. Modan, A. Mancuso, M. P. Rosen, M. I. Cedars.

3:45 pm O-19
DOES BODY SIZE AFFECT MEASURES OF OVARIAN RESERVE IN LATE REPRODUCTIVE AGE WOMEN?
I. H. Su, C. R. Gracia, M. D. Sammel, H. Lin, E. W. Freeman.

4:00 pm O-20
PREDICTING MENOPAUSE BY ORDINAL DISCRETE MARKOV TRANSITION MODEL.
Z. Liu, W. Guo, M. D. Sammel, H. Liu, E. W. Freeman.

4:15 pm O-21
SURGICAL MENOPAUSE INDUCES A KEY COLLAGEN DEGRADING ENZYME.
W. Zong, K. M. Debes, P. A. Moalli.

4:30 pm O-22
EFFECT OF SOY SUPPLEMENTATION ON REGIONAL FAT, BONE MINERAL CONTENT, AND LEAN MASS IN POSTMENOPAUSAL WOMEN.
D. R. Christie, B. C. Cooper, C. K. Sites.

4:45 pm O-23
GENE EXPRESSION PROFILING OF CARDIOVASCULAR DISEASE MARKERS IN RESPONSE TO HORMONE THERAPY IN POSTMENOPAUSAL CORONARY ARTERY VASCULAR ENDOTHELIUM.
M. Sprague, C. L. Cook, D. D. Taylor, C. Gercel-Taylor.

Back to the Top

NURSES PROFESSIONAL GROUP ABSTRACTS
Room: 209ABC
3:00 pm-5:00 pm

Moderators:
Janice E. Copeland, B.S.N.
Maria M. Jackson, R.N., M.A.

3:00 pm O-24
THE ABC'S OF EMOTIONAL HEALTH: NURSING ASSESSMENT OF WOMEN WITH SPONTANEOUS 46,XX PRIMARY OVARIAN INSUFFICIENCY (PREMATURE OVARIAN FAILURE).
V. Vanderhoof, J. Ventura, S. Covington, V. Popat, D. Koziol, L. M. Nelson.

3:15 pm O-25
INTRAUTERINE INSEMINATION (IUI) OUTCOMES IN CASES PERFORMED BY NURSES AS COMPARED WITH CASES PERFORMED BY PHYSICIANS.
J. U. Klein, D. Kuleta, J. C. Petrozza.

3:30 pm O-26
MOTIVATIONS, COMPENSATION AND ANONYMITY IN OOCYTE DONORS FROM 38 A.R.T. CENTERS IN THE UNITED STATES.
M. M. Fusillo, A. Shear.

3:45 pm O-27
A STUDY ON PREDICTORS RELATING TO MARITAL SATISFACTION OF INFERTILE COUPLES.
K. Y. Kim, T. Y. Park, H. J. Won, Y. T. Kim, H. W. Kim, T. K. Yoon.

4:00 pm O-28
WOMEN'S SATISFACTION WITH MANUAL VACUUM ASPIRATION TECHNIQUE IN A RECURRENT PREGNANCY LOSS CLINIC.
L. N. Dobney, C. Maurer, E. Houlihan, V. Hayes, S. Rhone.

4:15 pm O-29
TAKING THE PULSE OF AMERICA'S WOMEN'S HEALTH NURSES: A SURVEY OF KNOWLEDGE AND OPINIONS ON FERTILITY AND OOCYTE DONATION.
K. R. Hammond, N. A. Cataldo.

4:30 pm O-30
STRATEGIES FOR RECRUITMENT OF MINORITY WOMEN FOR CLINICAL RESEARCH TRIALS.
W. K. Blocker, A. Y. Armstrong, E. Levens, L. Nieman.

4:45 pm O-31
"MY FAMILY HEALTH PORTRAIT": NURSING APPLICATION OF A WEB-BASED TOOL TO EVALUATE WOMEN WITH PRIMARY OVARIAN INSUFFICIENCY (PREMATURE OVARIAN FAILURE).
V. H. Vanderhoof, T. Prodanov, J. F. Jenkins, J. L. Ventura, K. A. Calis, L. M. Nelson.

Back to the Top

FERTILITY PRESERVATION SPECIAL INTEREST GROUP ABSTRACTS
Room: 206
3:00 pm-5:00 pm

Moderators:
Kutluk Oktay, M.D.
Pasquale Patrizio, M.D.

3:00 pm O-32
TIME COURSE OF REVASCULARIZATION IN HUMAN OVARIAN TISSUE AFTER HETEROTOPIC TRANSPLANTATION IN NOD-SCID MICE.
H. D. Long, C. Q. Zhou, Y. B. Li.

3:15 pm O-33
FERTILITY PRESERVATION WITH OVARIAN CRYOPRESERVATION: A DECADE OF EXPERIENCE.
A. Elassar, O. Oktem, K. Oktay.

3:30 pm O-34
CRYOPROTECTANT LOADING FROM THE PERSPECTIVE OF OOCYTE CYTOSKELETON.
A. Eroglu, E. Szurek.

3:45 pm O-35
PROSPECTIVE RANDOMIZED COMPARISON OF HUMAN OOCYTE FREEZING AND VITRIFICATION: AN UPDATE.
J. Fioravanti, J. R. Alegretti, P. A. Hassun, E. L. A. Motta, P. C. Serafini, G. D. Smith.

4:00 pm O-36
SURVEY OF 105 BABIES BORN AFTER SLOW-COOLING OOCYTE CRYOPRESERVATION.
A. Borini, M. Cattoli, S. Mazzone, M. R. Trevisi, M. Nalon, I. Iadarola.

4:15 pm O-37
GENETICS AND HEALTH OF CHILDREN BORN FROM CRYOPRESERVED OOCYTES.
I. Tur-Kaspa, M. Gal, A. Horwitz.

4:30 pm O-38
IMPACT OF PREVIOUS CHEMOTHERAPY ON OVARIAN PRODUCTION OF ESTRADIOL, PROGESTERONE, AND AMH: AN IN VITRO CONTROLLED STUDY.
O. Oktem, K. Oktay.

4:45 pm O-39
ANTI-MULLERIAN HORMONE (AMH) LEVELS PRIOR TO, DURING AND AFTER CHEMOTHERAPY FOR LYMPHOMA: A LONGITUDINAL STUDY IN 17 WOMEN.
C. Decanter, P. Pigny, F. Morschauser, C. Galloo, C. Lefebvre, D. Dewailly.

Back to the Top

CLINICAL FEMALE INFERTILITY AND GYNECOLOGY ABSTRACTS
Room: 202A
3:00 pm-5:00 pm

Moderators:
Meike L. Uhler, M.D.
Samantha M. Pfeifer, M.D.

3:00 pm O-40
CRITICAL EVALUATION OF THE ROLE OF MAGNETIC RESONANCE IMAGING (MRI) OF THE SELLA TURCICA IN PATIENTS WITH ASYMPTOMATIC HYPERPROLACTINEMIA (HYPERPRL).
M. Pravdin, S. L. Feigenbaum.

3:15 pm O-41
EFFECTS OF METFORMIN PLUS LIFESTYLE MODIFICATION ON MENSTRUAL CYCLE AND BODY MASS INDEX ARE NOT INFLUENCED BY INSULIN RESISTANCE:A 16 WEEK, DOUBLE-BLIND, CONTROLLED, RANDOMISED STUDY IN PCOS.
A. R. Machlitt, E. Steinheim, B. F. Pfueller.

3:30 pm O-42
UTILIZATION OF THE ESSURE® MICRO-INSERT FOR THE TREATMENT OF HYDROSALPINX PRIOR TO IN VITRO FERTILIZATION.
D. I. Galen.

3:45 pm O-43
COMPARATIVE GENOMIC HYBRIDIZATION ANALYSIS OF SPONTANEOUSLY ABORTED TISSUE: COMPARISON WITH TRADITIONAL KARYOTYPING.
A. Skillern, E. Kovanci, H. M. T. El- Zimaity, L. J. McKenzie, J. E. Buster, S. A. Carson.

4:00 pm O-44
ORAL DIINDOLYLMETHANE (DIM): A NONSURGICAL TREATMENT FOR CERVICAL DYSPLASIA.
N. Montemarano, G. Del Priore, D. Gudipudi, A. Nair, A. Arslan.

4:15 pm O-45
CAESAREAN SECTION AND TUBAL INFERTILITY: IS THERE AN ASSOCIATION?
L. Saraswat, M. Porter, S. Bhattacharya, S. Bhattacharya.

4:30 pm O-46
EXOGENOUS FOLLICLE STIMULATING HORMONE AND RISK OF ANEUPLOIDY.
L. K. Shahine, A. A. Milki, L. M. Westphal, R. B. Lathi.

4:45 pm O-47
A MULTICENTER, PROSPECTIVE, RANDOMIZED, OPEN COMPARATOR STUDY ON THE TREATMENT OF OVULATORY MENORRHAGIA WITH TRANEXAMIC ACID AND NORETHISTERONE IN MAINLAND CHINA.
Y. Zhang, F. He, S. Li, Z. Cao, S. Lv, J. Lu.

Back to the Top

MALE FACTOR: ART ABSTRACTS
Room: 204BC
3:00 pm-5:00 pm

Moderators:
William E Gibbons, M.D.
Elizabeth S. Ginsburg, M.D.

3:00 pm O-48
THE LEVEL OF SPERM VACUOLES IN THE FRESH POSTPROCESSED SPERM SAMPLE SIGNIFICANTLY AFFECTS IVF CYCLE OUTCOMES.
N. Bar-Chama, J. Schiff, M. Luna, B. Dann, A. B. Copperman, J. Barritt.

3:15 pm O-49
EVALUATION OF SPERM CHROMATIN INTEGRITY AND SEMINAL QUALITY IN HIV POSITIVE PATIENTS.
F. Ayala A, A. Morales, M. Merino, E. Gonzalez, L. Sordia, V. Oscar.

3:30 pm O-50
CHARACTERIZATION OF MALE GERM-LINE STEM CELLS OBTAINED FROM HUMAN ADULT TESTICULAR TISSUES.
D. R. Lee, J. J. Lim, S. Y. Kim, S. H. Song, T. K. Yoon, K.-S. Kim.

3:45 pm O-51
EVALUATION OF MALE TRANSLOCATION PATIENTS UNDERGOING ART.
A. L. Davis, M. A. Witt, C. W. Elsner, D. Mitchell-Leef, Z. P. Nagy, T. C. Callaghan.

4:00 pm O-52
FREQUENT EJACULATION. A PILOT STUDY OF CHANGES IN SPERM DNA DAMAGE AND SEMEN PARAMETERS USING DAILY EJACULATION.
D. J. Greening.

4:15 pm O-53
THE CHANCE OF HAVING A HEALTHY NORMAL CHILD FOLLOWING INTRACYTOPLASMIC MORPHOLOGICALLY-SELECTED SPERM INJECTION (IMSI) TREATMENT IS HIGHER COMPARED TO CONVENTIONAL IVFICSI TREATMENT.
A. Berkovitz, F. Eltes, M. Paul, E. Adrian, B. Benjamin.

4:30 pm O-54
THE IMPACT OF PATERNAL AGE ON ANEUPLOIDY RATES IN FIRST TRIMESTER PREGNANCY LOSSES.
V. A. Kushnir, R. T. Scott, J. L. Frattarelli.

4:45 pm O-55
CHANGES OVER TIME OF TESTICULAR SPERM EXTRACTION (TESE) WITH IVF/ICSI FOR TREATMENT OF MALE FACTOR INFERTILITY.
R. Lee, B. Luke, P. S. Li, G. Schattman, M. Goldstein, P. N. Schlegel.

Back to the Top

MALE REPRODUCTION AND UROLOGY ABSTRACTS
Room: 151A
3:00 pm-5:00 pm

Moderators:
Arnold M. Belker, M.D.
Darius A. Paduch, M.D.

3:00 pm O-56
IDENTIFICATION OF GENE VARIABILITY WITHIN THE CONTRIN GENE OF AZOOSPERMIC PATIENTS.
S. Hammoud, D. M. Dunn, B. R. Emery, R. B. Weiss, D. T. Carrell.

3:15 pm O-57
INCREASED RISK OF TESTICULAR CANCER AMONG INFERTILE MEN.
T. J. Walsh, M. Schembri, P. J. Turek, M. S. Croughan.

3:30 pm O-58
SOY FOOD AND SOY ISOFLAVONE INTAKE IN RELATION TO SEMEN QUALITY PARAMETERS.
J. E. Chavarro, S. M. Sadio, T. L. Toth, R. Hauser.

3:45 pm O-59
THE FREQUENCY OF EPIDIDYMAL PROTEIN P34H DEFICIENCY IN MEN EVALUATED FOR INFERTILITY.
S. I. Moskovtsev, K. Jarvi, C. Legare, R. Sullivan, J. B. M. Mullen.

4:00 pm O-60
CHRONIC EXPOSURE TO ENVIRONMENTALLY-RELEVANT, LOWDOSES OF CADMIUM (CD) IN A RAT MODEL MIMICS EFFECTS ON SPERMATOGENESIS OBSERVED IN INFERTILE MEN WITH VARICOCELES.
S. H. Benoff, K. J. Auborn, D.-Z. Chen, J. L. Marmar, I. R. Hurley.

4:15 pm O-61
SPERM MOTILITY IS THE BEST PREDICTOR OF EJACULATORY DUCT OBSTRUCTION.
M. Khera, O. Mohamed, B. B. Najari, J. P. Alukal, E. D. Grober, L. I. Lipshultz.

4:30 pm-5:00 pm
MINI SYMPOSIUM
Epigenetics: What it is and How it Relates to Abnormal Reproductive Outcomes
Presenter: Victoria Cortessis, Ph.D.

Back to the Top

OTHER: ART ABSTRACTS
Room: 207B
3:00 pm-5:00 pm

Moderators:
Eric S. Surrey, M.D.
James M. Goldfarb, M.D.

3:00 pm O-62
FINDING OF A NEW REGULATOR OF MEIOSIS PROMOTING FACTOR (MPF) IN MEIOTIC PROGRESSION OF THE MOUSE OOCYTES.
K.-A. Lee, E.-Y. Kim, E.-H. Lee, K.- H. Kim, Y.-S. Kim, J. Bae.

3:15 pm O-63
EARLY ADMINISTRATION OF ADDITIONAL VAGINAL PROGESTERONE SUPPORT HAS A DETRIMENTAL EFFECT ON IMPLANTATION RATES IN EMBRYO RECIPIENT CYCLES.
C. Adams, L. Anderson, L. Wheeler, S. Wood.

3:30 pm O-64
DERIVATION OF THE FIRST CUSTOM-MADE PERSONAL EMBRYONIC STEM CELLS. A PILOT STUDY.
A. Krtolica, D. Ilic, R. Foulk, E. Caceres, C. Simon, O. Genbacev.

3:45 pm O-65
EXTENDED 35 TO 38 HOURS AFTER HCG PRIMING FOR IMMATURE OOCYTE RETRIEVAL INCREASES OOCYTE MATURATION RATE IN IVM TREATMENT.
W.-Y. Son, J. T. Chung, S. Cui, S. Elizur, B. Buckett, R.-C. Chian.

4:00 pm O-66
DOES RECOMBINANT LH COMBINED TO PROGESTERONE FOR LUTEAL PHASE INTERFERE IN THE OUTCOME OF ASSISTED REPRODUCTION TECHNIQUE CYCLES?
S. Geber, L. Maia, I. Lauar, M. P. Valle, M. A. C. Sampaio.

4:15 pm O-67
DERIVATION OF THE HUMAN EMBRYONIC STEM CELL LINE FROM THE TWO BLASTOMERES OF NON-VIABLE EMBRYOS.
D. Ilic, O. Genbacev, C. Simon, R. Foulk, A. Krtolica.

4:30 pm O-68
ELECTIVE SINGLE EMBRYO TRANSFER (ESET): SUCCESSFUL PROGRESSIVE IMPLEMENTATION OF 450 CYCLES OF ESET AMONG 12,135 IVF-ET CYCLES FROM 2002-2006 NEARLY ELIMINATED TWIN PREGNANCIES AMONG SELECT PATIENTS. 
R. J. Stillman, J. R. Graham, K. S. Richter.

4:45 pm O-69
THE ART AND SCIENCE OF REPRODUCTIVE DONOR SCREENING: POOLED TESTING (PT) VS. INDIVIDUAL DONOR NUCLEIC ACID TESTING (ID NAT) AND FALSE POSITIVE TEST RATE.
J. B. Gorlin, M. Janzen, J. VanHulzen.

Back to the Top

OUTCOME PREDICTORSCLINICAL:ART ABSTRACTS
Room:150AB
3:00 pm-5:00 pm

Moderators:
R. Stanley Williams, M.D.
Bill Yee, M.D.

3:00 pm O-70
THE EFFECT OF EARLY FETAL LOSSES ON TWIN ASSISTEDCONCEPTION PREGNANCY OUTCOMES.
B. Luke, M. B. Brown, D. A. Grainger, J. E. Stern, N. Klein, M. I. Cedars.

3:15 pm O-71
INTRAFOLLICULAR ANTIMULLERIAN HORMONE (AMH) LEVELS POSITIVELY CORRELATE WITH FOLLICLE SENSITIVITY TO FOLLICLE STIMULATING HORMONE (FSH) AND ARE ELEVATED IN POLYCYSTIC OVARY SYNDROME (PCOS).
D. A. Dumesic, T. G. Lesnick, J. Booher, A. Wong, G. D. Ball, D. H. Abbott.

3:30 pm O-72
OVULATION TRIGGERING WITH URINARY VS. RECOMBINANT HCG IN CNRH-ANTAGONIST IVF CYCLES WITH SINGLE BLASTOCYST TRANSFER. A RANDOMISED CONTROLLED TRIAL.
E. G. Papanikolaou, P. Devroey, H. Fatemi, W. Verpoest, H. Tournaye.

3:45 pm O-73
METABOLOMIC ASSESSMENT OF DAY 2 (D2) EMBRYOS BASED ON PREGNANCY OUTCOME AFTER SINGLE EMBRYO TRANSFER (SET).
O. Kato, S. Teramoto, H. Morita, L. Botros, P. Roos, D. Burns.

4:00 pm O-74
ABDOMINAL VERSUS TRANSVAGINAL ULTRASOUND GUIDED EMBRYO TRANSFER: PRELIMINARY RESULTS OF A RANDOMIZED CLINICAL TRIAL.
N. Porat, B. E. Biaggio, S. E. Ansay, L. M. Boehnlein, M. D. Evans, S. R. Lindheim.

4:15 pm O-75
OPTIMIZING THE NUMBER OF CLEAVAGE STAGE EMBRYOS TO TRANSFER ON DAY 3 IN WOMEN 38 AND OLDER: A SART DATABASE STUDY.
J. E. Stern, M. B. Goldman, H. Hatasaka, T. A. MacKenzie, E. S. Surrey, C. Racowsky.

4:30 pm O-76
DELETERIOUS CONSEQUENCES OF VANISHING TWINS (VT) IN IVF/ICSI PREGNANCIES: A LARGE STUDY FROM A SINGLE INSTITUTION.
S. D. Spandorfer, O. K. Davis, Z. Rosenwaks.

4:45 pm O-77
THE SEX-RATIO OF SINGLETON OFFSPRING IN ASSISTED-CONCEPTION PREGNANCIES. 
B. Luke, M. B. Brown, D. A. Grainger, J. E. Stern, V. L. Baker, E. Ginsburg.

Back to the Top

OUTCOME PREDICTORSLABORATORY:ART ABSTRACTS
Room: 152AB
3:00 pm-5:00 pm

Moderators:
G. David Ball, Ph.D.
Michael W. Vernon, Ph.D.

3:00 pm O-78
EMBRYO BIOPSY: THE FATE OF BIOPSIED ABNORMAL PRONUCLEAR EMBRYOS.
N. Noyes, E. Fino, C. McCaffrey, A. Adler, L. Krey, J. Grifo.

3:15 pm O-79
DELETERIOUS EFFECT OF TOBACCO ON IVF OUTCOME AND OVARIAN RESERVE AS REFLECTED BY SERUM ANTI MULLERIAN HORMONE (AMH).
P. Barriere, T. Freour, D. Masson, S. Mirallie, M. Jean.

3:30 pm O-80
RELATIONSHIP OF REACTIVE OXYGEN SPECIES LEVELS IN DAY 3 CULTURE MEDIA WITH THE OUTCOME OF IVF/ICSI CYCLES.
M. A. Bedaiwy, R. Mahfouz, J. Goldberg, K. Miller, A. Agarwal, T. Falcone.

3:45 pm O-81
IMPACT OF SPERM DNA FRAGMENTATION ON EMBRYO QUALITY, PREGNANCY AND MISCARRIAGE RATE IN IVF CYCLES OF PATIENTS AND OOCYTES RECIPIENTS.
M. Esbert, A. Pacheco, M. San Celestino, F. Vidal, A. Ballesteros, G. Calderon.

4:00 pm O-82
RESPIRATION MEASUREMENTS OF HUMAN OOCYTES CORRELATE WITH OOCYTE COMPETENCE.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing.

4:15 pm O-83
NOVEL APPROACH TO VIABILITY TESTING BY NON-INVASIVE METABOLOMIC PROFILING (METPRO) OF BIOMARKERS OF OXIDATIVE METABOLISM (OM) FROM BLASTOCYSTS USED FOR SINGLE EMBRYO TRANSFER (SET).
M. Tucker, J. Kaminsky, R. Stillman, L. Botros, P. Roos, D. Burns.

4:30 pm O-84
FORMULA PREDICTING PROGRESSION TO BLASTOCYST USING CHARACTERISTICS FROM THE FIRST THREE DAYS OF DEVELOPMENT OF 34,708 EMBRYOS.
M. I. Shamonki, D. Glujovsky, C. M. Wambach, K. A. Miller, P. A. Bergh.

4:45 pm O-85 WITHDRAWN

Back to the Top

OVARIAN STIMULATION: ART ABSTRACTS
Room: 147AB
3:00 pm-5:00 pm

Moderators:
Suheil J. Muasher, M.D.
Glenn L. Schattman, M.D.

3:00 pm O-86
SAFETY OF OVARIAN STIMULATION WITH LETROZOLE AND GONADOTROPINS IN BREAST CANCER PATIENTS UNDERGOING EMBRYO OR OOCYTE CRYOPRESERVATION: A PROSPECTIVE CONTROLLED STUDY.
A. M. A. Azim, K. Oktay.

3:15 pm O-87
EMBRYO ANEUPLOIDIES IN GNRH AGONIST VS GNRH ANTAGONIST CYCLES. EXPERIENCE OF 2,000 CYCLES.
E. Bosch, M. C. Rubio, A. Mercader, C. Simon, J. Remohi, A. Pellicer.

3:30 pm O-88
COMPARISON OF SERUM AND FOLLICULAR FLUID HORMONE LEVELS WITH RECOMBINANT AND URINARY HUMAN CHORIONIC GONADOTROPIN DURING IN VITRO FERTILIZATION.
P. Kovacs, T. Kovats, G. Szmatona, A. Bernard, J. Zadori, S. G. Kaali.

3:45 pm O-89
FIRST INTENTION IVF PROTOCOL FOR POLYCYSTIC OVARIES (PCO): SHOULD WE PREFER DUAL SUPPRESSION? PRELIMINARY RESULTS OF A RANDOMIZED STUDY.
C. Decanter, L. Seurin, K. Pocate-Cheriet, P. Thomas, D. Dewailly.

4:00 pm O-90
A STUDY OF 92 PATIENT CYCLES USING THE GANIRELIX SALVAGE PROTOCOL IN WOMEN AT RISK OF OHSS.
H. Browne, B. J. Stegmann, F. W. Larsen, A. James, M. Payson, J. Segars.

4:15 pm O-91
THE LONG-ACTING RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE ANALOG RHFSH-N4 IS SUPERIOR TO RHFSH FOR ENHANCING OVULATION AND FERTILIZATION IN MICE.
B. Yu, R. K. Trousdale, P. A. Vardhana, S. V. Pollak, N. W. Husami, J. W. Lustbader.

4:30 pm O-92
GENE EXPRESSION PROFILE IN HUMAN CUMULUS CELLS STIMULATED WITH PURIFIED FSH (HMG) OR RECOMBINANT FSH (RECFSH) COMBINED WITH GONADOTROPIN-RELEASING HORMONE AGONIST (GNRH-A) OR ANTAGONIST (GNRH-ANT).
S. Hamamah, V. Loup, T. Rème, J. De Vos, H. Dechaud, S. Gasca.

4:45 pm O-93
EFFICACY AND SAFETY OF HIGHLY PURIFIED HMG VERSUS RECOMBINANT FOLLICLE STIMULATING HORMONE: A META-ANALYSIS.
H. G. Al-Inany, A. M. Abou-Setta, R. T. Mansour, G. I. Serour, M. A. Aboulghar.

Back to the Top

PROCEDURES AND TECHNIQUES-LABORATORY:ART ABSTRACTS
Room: 143AB
3:00 pm-5:00 pm

Moderators:
Kimball O. Pomeroy, Ph.D.
J. David Wininger, Ph.D.

3:00 pm O-94
DEVELOPMENT OF A MICROFLUIDIC PLATFORM TO MEASURE METABOLIC ACTIVITY OF PREIMPLANTATION EMBRYOS.
J. P. Urbanski, M. T. Johnson, D. D. Craig, D. L. Potter, D. K. Gardner, T. Thorsen.

3:15 pm O-95
a-LIPOIC ACID: AN ANTIOXIDANT THAT IMPROVES EMBRYO DEVELOPMENT AND PROTECTS AGAINST OXIDATIVE STRESS.
D. W. Linck, M. G. Larman, D. K. Gardner.

3:30 pm O-96
ASSOCIATION OF CATALASE ENZYMATIC ACTIVITY IN BOVINE FOLLICULAR FLUID WITH BOTH THE PHASES OF FOLLICULOGENESIS AND THE STAGES OF THE ESTRUS CYCLE.
S. Gupta, H. Chowdary, R. Koli, S. Czerniak, C. Combelles, A. Agarwal.

3:45 pm O-97
PICSI™ VERSUS ICSI: STATISTICALLY SIGNIFICANT IMPROVEMENT IN CLINICAL OUTCOMES IN 240 IN VITRO FERTILIZATION (IVF) PATIENTS.
K. C. Worrilow, H. T. Huynh, J. B. Bower, A. R. Anderson, W. Schillings, J. L. Crain.

4:00 pm O-98
AMMONIUM BUILD UP IN CULTURE MEDIA ALTERS HUMAN EMBRYONIC METABOLISM AND GENE EXPRESSION.
D. K. Gardner, B. Hamilton, B. R. McCallie, J. Stevens, W. B. Schoolcraft, M. G. Katz-Jaffe.

4:15 pm O-99
AUTOMATED DETECTION OF CELL DIVISION AND MOVEMENT IN TIME-LAPSE IMAGES OF DEVELOPING BOVINE EMBRYOS CAN IMPROVE SELECTION OF VIABLE EMBRYOS.
N. B. Ramsing, J. Berntsen, H. Callesen.

4:30 pm O-100
MICROSORT® PROCESSED SPERM REQUIRES ICSI; EMBRYO SELECTION IS ENHANCED BY PGD FOR ANEUPLOIDY WHEN USED FOR GENDER SELECTION IN SEX-LINKED DISORDERS.
N. Noyes, B. Melander, A. Adler, J. Grifo, E. Fino, L. C. Krey.

4:45 pm O-101
INHIBITED EMBRYO DEVELOPMENT AT SPECIFIC CELL-STAGE IS DEPENDENT ON TYPE OF NANOPARTICLES USED FOR IN VITRO TAGGING.
T. L. Fynewever, J. D. Jacobson, W. C. Patton, J. U. Corselli, P. J. Chan.

Back to the Top

Members Meetings
5:00 pm-5:30 pm

• The Society of Reproductive Surgeons
  Room: 151B

• Menopause Special Interest Group
  Room: 201

• Fertility Preservation Special Interest Group
  Room: 206

• ESHRE
  Room: 146C

• Chinese Special Interest Group
  Room: 151A

• FLASEF
  Room: 204A

• Environment and Reproduction Special Interest Group
  Room: 148

• Health Disparities Group
  Room: 154AB

• Nutrition Group
  Room: 159AB

Back to the Top

Poster Session
Wine & Cheese Reception
Location: Hall E

ASRM invites you to meet the poster presenters Monday and Tuesday evenings from 5:30 pm-7:00 pm and enjoy a sampling of delicious wines and cheeses. Authors of posters P-1 through P-448 will present their posters Monday evening; authors of posters P-449 through P-886 will present their posters Tuesday evening.

Supported by Organon USA Inc.

Please note that on Monday, posters will be open from noon until 7:00 pm. On Tuesday, posters will open at 9:30 am and close at 7:00 pm. On Wednesday, posters will open at 9:30 am and will conclude at 12:00 pm. ASRM cannot be responsible for removing and/or returning posters. All posters not removed will be discarded.

Go back to Sunday's Overview | Go to Tuesday's Overview

By accessing and using the ASRM Web Site, you agree to be bound by 
the ASRM Web Site Terms and Conditions of Use.  

View the ASRM Non Discrimination Policy

Copyright 1996-2008 ASRM, All Rights Reserved
American Society for Reproductive Medicine

Listed on Infertility Resources
Developed and hosted by Internet Health Resources